HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification and therapy for patients with heart failure with preserved ejection fraction: An expert opinion of the Heart Failure Association of the Polish Cardiac Society.

Abstract
Diagnosis of heart failure with preserved ejection fraction (HFpEF) may be challenging owing to the heterogeneous clinical presentation and comorbidities in this population of patients, along with the limited availability of standard diagnostic tools, including natriuretic peptide tests and functional testing. This expert opinion summarizes the current state of knowledge on the identification and therapy for patients with HFpEF based on recent European and American recommendations. This expert opinion aims to aid clinicians in HFpEF management.
AuthorsMałgorzata Lelonek, Agnieszka Pawlak, Ewa Straburzyńska-Migaj, Jadwiga Nessler, Paweł Rubiś
JournalKardiologia polska (Kardiol Pol) Vol. 82 Issue 2 Pg. 247-254 ( 2024) ISSN: 1897-4279 [Electronic] Poland
PMID38230496 (Publication Type: Journal Article)
Topics
  • Humans
  • Heart Failure (therapy, drug therapy)
  • Expert Testimony
  • Poland
  • Stroke Volume
  • Comorbidity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: